Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy

E. G. Hanania, R. E. Giles, J. Kavanagh, D. Ellerson, Z. Zu, T. Wang, Y. Su, A. Kudelka, Z. Rahman, F. Holmes, G. Hortobagyi, D. Claxton, C. Bachier, P. Thall, S. Cheng, J. Hester, J. M. Ostrove, R. E. Bird, A. Chang, M. KorblingD. Seong, R. Cote, T. Holzmayer, E. Mechetner, S. Heimfeld, R. Berenson, B. Burtness, C. Edwards, R. Bast, M. Andreeff, R. Champlin, A. B. Deisseroth

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences